news

Our latest
Press Releases & Updates

Latest press releases

RetinAI and PulseSight Therapeutics Expand Collaboration to Support Advancement of PST-611 Gene Therapy Program for Geographic Atrophy into Phase 2a

RetinAI and PulseSight Therapeutics expand their collaboration to support PST-611, an investigational gene therapy for geographic atrophy, from AI-based analysis of Phase 1 OCT data through the upcoming Phase 2a trial.

Heidelberg Engineering and RetinAI Expand Ophthalmology Offering with Selected RetinAI Discovery® for Clinics Solutions

RetinAI OCT Atlas® is now CE-marked for Clinical Use: one algorithm for AMD, DR, DME, and Glaucoma

RetinAI OCT Atlas® is now CE-marked under EU MDR 2017/745 for clinical use across AMD, Diabetic Retinopathy, DME, and Glaucoma, validated in the DILL study across 124 patients and three OCT devices.

RetinAI & OptymEdge Collaborate to Accelerate Ophthalmic Drug Development Through AI-Powered Reading Center Solutions

Latest updates

NVIDIA GTC Europe 2018 [OCTOBER’18]

RetinAI was one of the 10 startup to present on the NVIDIA GTC Europe Inception Awards 2018. Hundreds of applications, 70 teams in the pitching semi-finals and only 10 teams in the final. What a great opportunity to show the world how Artificial Intelligence is going to change the standard of eye care in 2019.

‍

18th Euretina Congress [SEPTEMBER’18]

Our team members travelled to the European Society of Retina Specialists (EURETINA) in Vienna, 20-23 September, to present our latest products to make eye hospitals more efficient using Artificial Intelligence (AI). Stay tuned if you want to learn more about how AI is going to change the life of many eye care professionals in the near future.

RetinAI at the NVIDIA Inception Awards [SEPTEMBER’18]

RetinAI is honoured to be one of the 10 selected projects to attend the GTC Europe Inception Awards NVIDIA, taking place in Munich between 9-11th October 2018. Hundreds of applications, 70 teams in the pitching semi-finals and only 10 teams in the final. Next step will be to compete live at the GTC to get a chance to win $100.000 and a NVIDIA DGX Workstation!

‍

RetinAI at MICCAI'18 Labels [SEPTEMBER’18]

RetinAI participated in this year's edition of the annual International Conference on Medical Image Computing & Computer Assisted (MICCAI) in Granada, Spain, held on September 16-20.This year was the first time we sponsored the Large-Scale Annotation of Biomedical data and Expert Label Synthesis (LABELS) workshop at the event, offering a price to the winner of the competition for the best paper: 'Deep Learning Retinal Vessel Segmentation From a Single Annotated Example: An Application of Cyclic Generative Adversarial Neural Networks' by Praneeth Sadda, John A. Onofrey, and Xenophon Papademetris.

‍

Contact us for more informations! We are happy to hear from you!